Projects per year
Abstract
Pretransplant detection of KMT2Ar measurable residual disease ≥0.001% by quantitative polymerase chain reaction was associated with significantly inferior posttransplant survival (2-year relapse-free survival 17% vs 59%; P = .001) and increased 2-year cumulative incidence of relapse (75% vs 25%, P = .0004).
| Original language | English |
|---|---|
| Pages (from-to) | 2554-2557 |
| Number of pages | 4 |
| Journal | Blood |
| Volume | 144 |
| Issue number | 24 |
| DOIs | |
| Publication status | Published - 12 Dec 2024 |
Projects
- 2 Finished
-
Transforming the treatment landscape in elderly Acute Myeloid Leukaemia (AML)
Wei, A. (Primary Chief Investigator (PCI)), Bohlander, S. K. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)) & Levis, M. (Chief Investigator (CI))
1/05/19 → 31/12/22
Project: Research
-
Translational Research Program to Advance Clinical Outcomes in Acute Myeloid Leukaemia
Wei, A. (Primary Chief Investigator (PCI))
1/01/18 → 31/12/22
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver